Actinium Pharmaceuticals reported $-5.69M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 6.72B 1.99B Jun/2026
Actinium Pharmaceuticals USD -5.69M 1.81M Sep/2025
Amgen USD 4.61B 777M Jun/2026
Bioline Rx USD -2.34M 1.05M Mar/2026
Capricor Therapeutics USD -29.16M 2.87M Dec/2025
Pfizer USD -180M 5.16B Jun/2026